Unicycive Therapeutics, Inc. UNCY
NASDAQ · United States · Health Technology
$4.22-0.33 (-7.25%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.06 | -0.47 | +87.3% | $0 | — | +8.0%$5.00→$5.40 |
| Q1 2026 | 2026-05-12 | -0.54 | -0.55 | +1.8% | — | — | +7.0%$7.95→$8.51 |
| Q4 2025 | 2026-03-30 | -0.82 | -0.46 | -78.3% | — | — | +3.0%$6.39→$6.58 |
| Q3 2025 | 2025-11-12 | -0.33 | -0.53 | +37.7% | — | — | +11.3%$4.79→$5.33 |
| Q2 2025 | 2025-08-14 | -0.52 | -0.70 | +25.7% | — | — | — |
| Q1 2025 | 2025-05-14 | -0.50 | -0.62 | +19.4% | — | — | — |
| Q4 2024 | 2025-03-31 | -2.60 | -0.70 | -271.4% | — | — | — |
| Q3 2024 | 2024-11-13 | -0.50 | -1.52 | +67.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.